Answers are grounded in this paper and cite their sources.
Cidofovir ((S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine) is an antiviral nucleotide analogue with significant activity against almost all types of DNA viruses [1]. It has been approved for treatment of cytomegalovirus (CMV) retinitis and for infections by other herpes viruses, in patients with acquired immunodeficiency syndrome (AIDS) [2,3]. We report the second case of cidofovir‐induced acute renal failure that led to end‐stage renal failure (ESRF) in a few months. A 34‐year‐old man with AIDS was admitted to our nephrology unit in December 1999 because of non‐oliguric acute renal failure after cidofovir administration. The patient had a long history of HIV‐positive disease, and he had developed AIDS in 1992. From 1992 to 1999, his medical history included oropharyngeal candidosis bouts, herpes genitalis, and resistant cutaneous Kaposi's sarcoma. Since 1990 many anti‐retroviral treatments had been introduced, including highly active anti‐retroviral therapies (HAART), with few effects on CD4+ cell counts and HIV RNA load. Since March 1999, HAART consisted of a combination of amphonavir, abacavir and lamivudine. The patient was also treated with trimethoprim‐sulfamethoxazole (80/400 mg/qd), rifabutine (150 mg/qd) and oral ganciclovir (250 mg/bid). Cidofovir treatment was introduced in March 1999 in order to be active against human herpes virus‐8 (HHV‐8) and against resistant HIV (K103N mutation), and to prevent CMV retinitis. It was administered intravenously at a dose of 5 mg/kg once every 2 weeks, and each injection was associated with administration of 2 l of i.v. normal saline. Four grams of probenecid were also given during cidofovir injections, in March and April 1999, but this drug was then stopped because of severe erythrodermia. Between March and November 1999, serum creatinine was 80–85 μmol/l (i.e. glomerular filtration rate estimated according to the Cockcroft and Gault formula was 82–87 ml/min) and urinary dipstick analysis was negative for proteins, but glycosuria appeared in May 1999.
No takes yet. Share an insight, caveat, or question.
Meier et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: